SpaceX shares fall below $135 IPO price after Starship abort
Synopsis
Key Takeaways
SpaceX shares closed below their initial public offering (IPO) price for the first time on 17 July, after the aerospace company aborted the planned launch of its Starship rocket, deepening a losing streak that has now stretched to five consecutive sessions since the stock's market debut.
The Stock's Slide
Shares settled at $131.11, a decline of 3.08% for the day, slipping beneath the IPO price of $135. The selling pressure intensified in after-hours trading, with the stock touching as low as $124 following news of the aborted launch. The decline extends a run that began shortly after SpaceX's 12 June listing — an event that raised approximately $86 billion and was widely reported as the largest IPO in history.
What Triggered the Abort
The Starship test flight — the 13th in the programme's history and the second for the upgraded V3 variant — was scheduled to lift off from SpaceX's Starbase facility in South Texas during a 90-minute launch window that opened at 6:45 pm ET on Thursday. Minutes into the window, the company announced it was 'standing down for the day' after the launch sequence was automatically aborted during engine ignition.
SpaceX chief executive Elon Musk later posted on X that the abort was triggered automatically when several engines failed to start. 'Some of the engines didn't start, triggering an automatic launch abort. Now offloading propellant. Next launch attempt hopefully in a few days,' Musk wrote. In a follow-up post, he said two Raptor engines would be removed and replaced, with the next attempt most likely early the following week.
Context: A Pattern of Engine Trouble
The abort is not an isolated setback. The previous V3 test flight in May achieved liftoff, but multiple engines on the rocket's lower stage failed to reignite, causing the vehicle to fall into the Gulf of Mexico before completing its mission. The Starship stands approximately 400 feet tall and is central to SpaceX's ambitions for deep-space travel and NASA's Artemis lunar programme.
Market Implications
For investors, the abort compounds concerns about execution risk at a company whose valuation was priced on ambitious launch cadences. The stock's breach of its IPO price within weeks of listing is a notable signal in a market that had greeted the debut with considerable enthusiasm. Analysts will now watch whether the next launch attempt — and its outcome — can stabilise sentiment, or whether further slippage below the IPO price accelerates institutional selling.